BioSpace News Archive

Problems with failing memory are common for many individuals as they grow older, and is particularly characteristic of patients with Alzheimer’s disease. Research shows that aging-related cognitive decline may be affected by Omega-3 levels and the health of cell membranes. Certain nutritional supplements developed to target

Dr. Horowitz, Dr. Weber Recognized for Scientific Impact and Business Success in the Biohealth Industry

- Today’s data published by the Canadian Institute for Health Information (CIHI) paints a bleak portrait of the impact of COVID-19 on Canada’s health workforce. According to the data, health care workers, who make up 8% of the labour workforce in this country, represent 19% of COVID cases. This confirms CMA’s long-standing concerns: the risk

CymaBay Therapeutics, Inc. announced that management will participate in three virtual investor conferences including Citi’s 15th Annual BioPharma Conference taking place September 9-10, 2020, the H.C. Wainwright 22nd Annual Global Investment Conference taking place September 14-16, 2020 and the Cantor Global Healthcare Conference taking place September 15-17, 2020.

Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by leveraging unparalleled insights into protein motion, today announced the first patient has been dosed in a first-in-human clinical trial of RLY-4008 enriched for patients with intrahepatic cholangiocarcinoma (ICC) and other advanced solid tumors harboring a fibroblast growth factor receptor 2 (FGFR2) alteration. RL

Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced that its management team will participate in the Cantor Fitzgerald Virtual Global Healthcare Conference which takes place September 15-17, 2020. Ron Rocca, President and CEO of Exagen, will engage in a fireside chat on September 15 at 2:40 pm EDT. A link to the live webcast of Mr. Rocca’s firesi

Adamis Pharmaceuticals Corporatio announced the results of its reconvened 2020 annual meeting of stockholders which was initially held August 20, 2020, and was adjourned until September 3, 2020

Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Morgan Stanley 18th Annual Global Healthcare Conference on Thursday, September 17, 2020 . Ev

FUJIFILM Sonosite , Inc., specialists in developing cutting-edge point-of-care ultrasound (POCUS) solutions, and part of the larger Fujifilm Healthcare portfolio, today announced that the company has received 510(k) Clearance from the U.S. Food & Drug Administration (FDA) for the company’s entire POCUS portfolio to sup

RUC-4 is the first and only GPIIb/IIIa inhibitor that is in clinical development as a simple, single subcutaneous injection treatment to potently and rapidly block all platelet aggregation pathways to improve outcomes for heart attack patients SAN DIEGO--( BUSINESS WIRE )-- CeleCor Therapeutics, Inc. announced positive data from the company’s completed phase 1 clinical study of RUC-4 which was published in the Journal of the American Heart Associa